Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India

Seetharamaiah Chittiprol, Adarsh Kumar, P. Satishchandra, K. Taranath Shetty, R. S. Bhimasena Rao, D. K. Subbakrishna, Mariyamma Philip, K. S. Satish, H. Ravi Kumar, Mahendra Kumar

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Human immunodeficiency virus type 1 (HIV-1) infection causes a wide spectrum of abnormalities in neurological, neuropsychological, and neuroendocrinological functions. Several studies report disturbance in autonomic nervous system (ANS) and hypothalamic pituitary-adrenal (HPA) axis function in HIV-1B infected individuals. However, no such investigations on the effect of HIV-1 clade C infection, particularly during the initial phase of the disease progression, have been reported. The present investigations were carried out longitudinally over a 2-year period at 12 monthly intervals in clinically asymptomatic HIV-1 clade C seropositive patients (n=120) and seronegative control subjects (n=29). We determined both the basal levels and the dynamic changes in plasma levels of norepinephrine (NE), epinephrine (E), adrenocorticotrophic hormone (ACTH) and cortisol (CORT). Studies were also extended longitudinally (at three separate yearly visits of each participant), to evaluate the response of autonomic and HPA axis to mirror star tracing challenge test (MSTCT) and the values were determined as area under the curve (AUC, corrected for baseline levels of NE, E, ACTH, and CORT). The findings show that the values of basal plasma NE levels, as well as NE response to MSTCT (AUC) at the first visit of HIV-1 seropositive individuals did not differ from those found in the control subjects (NE, pg/ml, HIV-1C=313.5±12.7 vs. controls=353.0±21.3; p=NS; AUC, HIV-1C=225±14.75 vs. controls=232.7±19.34; p=NS, respectively). At the subsequent two visits of HIV-1 positive patients however, NE response to MSTCT challenge was progressively attenuated (AUC=235±19.5 and 162.7±13.6; p<0.01 and 0.05, respectively) compared to that found at the first visit. On the other hand, plasma levels of E as well as E response to MSTCT at the first visit were significantly lower in HIV-1C seropositive individuals compared to those in the control subjects (pg/ml, HIV-1C=77.30±5.7 vs. controls=119.1+10.5; p<0.05; AUC, HIV-1C =83.29±7.5 vs. controls=172.3±18.9; p<0.001), but no further change was observed in AUC of E in response to MSTCT at the two subsequent yearly visits. The basal plasma levels of ACTH in HIV-1C seropositives were not different than in the control subjects (pg/ml: HIV-1C=20.0±0.9 vs. controls=23.1±1.6; p=NS), but ACTH response to MSTCT in HIV-1C seropositive patients at the first visit was lower than in the controls (AUC, HIV-1C=23.57±1.5 vs. controls=30.94±3.5; p<0.05), and fluctuated between high and low at the second and third visits (AUC, 28.89±2.3 and 21.69±2.36, respectively). However, the baseline plasma levels of cortisol as well as the response of cortisol to MSTCT (AUC) in HIV-1C seropositive individuals were higher than in the control subjects at the first visit (μg/dl, HIV-1C=9.83±0.39 vs. controls=6.3±0.56; p<0.05; AUC, HIV-1C=12.31±0.7 vs. control=9.18±0.9; p<0.05), and remained high at the two subsequent yearly follow up visits of HIV-1C (AUC, 11.8±0.86 and 11.98±0.77, respectively). These findings demonstrate attenuated autonomic functions, a disconnection between response of ACTH and cortisol to the MSTCT challenge, and an inverse relationship between plasma levels of catecholamine(s) and cortisol. Since plasma catecholamines and cortisol are the peripheral mediators of the autonomic and HPA axis function, the findings of this study reflect the overall adverse effect of HIV-1C infection on autonomic as well as HPA axis functions. The findings, apart from being the first to demonstrate the progressive dysregulation of autonomic nervous system and HPA axis function among HIV-1C infected seropositive individuals much ahead of the onset of acquired immunodeficiency syndrome (AIDS), also suggest that MSTCT, involving visuoconstructive cognitive abilities, is an effective stressor for unraveling the underlying dysfunctions in the neuroendocrine functions in health and disease.

Original languageEnglish
Pages (from-to)30-40
Number of pages11
JournalPsychoneuroendocrinology
Volume33
Issue number1
DOIs
StatePublished - Jan 1 2008

Fingerprint

HIV-1
India
HIV
Area Under Curve
Infection
Hydrocortisone
Norepinephrine
Adrenocorticotropic Hormone
Autonomic Nervous System
Catecholamines
Virus Diseases
Epinephrine
HIV Infections
Disease Progression
Acquired Immunodeficiency Syndrome

Keywords

  • ACTH
  • Autonomic nervous system
  • Cortisol
  • Epinephrine
  • HIV-1C
  • HPA-axis
  • Mirror star tracing challenge test
  • Norepinephrine

ASJC Scopus subject areas

  • Endocrinology
  • Endocrinology, Diabetes and Metabolism
  • Psychiatry and Mental health
  • Biological Psychiatry
  • Endocrine and Autonomic Systems
  • Psychology(all)

Cite this

Chittiprol, S., Kumar, A., Satishchandra, P., Taranath Shetty, K., Bhimasena Rao, R. S., Subbakrishna, D. K., ... Kumar, M. (2008). Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. Psychoneuroendocrinology, 33(1), 30-40. https://doi.org/10.1016/j.psyneuen.2007.09.006

Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. / Chittiprol, Seetharamaiah; Kumar, Adarsh; Satishchandra, P.; Taranath Shetty, K.; Bhimasena Rao, R. S.; Subbakrishna, D. K.; Philip, Mariyamma; Satish, K. S.; Ravi Kumar, H.; Kumar, Mahendra.

In: Psychoneuroendocrinology, Vol. 33, No. 1, 01.01.2008, p. 30-40.

Research output: Contribution to journalArticle

Chittiprol, S, Kumar, A, Satishchandra, P, Taranath Shetty, K, Bhimasena Rao, RS, Subbakrishna, DK, Philip, M, Satish, KS, Ravi Kumar, H & Kumar, M 2008, 'Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India', Psychoneuroendocrinology, vol. 33, no. 1, pp. 30-40. https://doi.org/10.1016/j.psyneuen.2007.09.006
Chittiprol S, Kumar A, Satishchandra P, Taranath Shetty K, Bhimasena Rao RS, Subbakrishna DK et al. Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. Psychoneuroendocrinology. 2008 Jan 1;33(1):30-40. https://doi.org/10.1016/j.psyneuen.2007.09.006
Chittiprol, Seetharamaiah ; Kumar, Adarsh ; Satishchandra, P. ; Taranath Shetty, K. ; Bhimasena Rao, R. S. ; Subbakrishna, D. K. ; Philip, Mariyamma ; Satish, K. S. ; Ravi Kumar, H. ; Kumar, Mahendra. / Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India. In: Psychoneuroendocrinology. 2008 ; Vol. 33, No. 1. pp. 30-40.
@article{ea28237552bc485f84d4dbc70117fcec,
title = "Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India",
abstract = "Human immunodeficiency virus type 1 (HIV-1) infection causes a wide spectrum of abnormalities in neurological, neuropsychological, and neuroendocrinological functions. Several studies report disturbance in autonomic nervous system (ANS) and hypothalamic pituitary-adrenal (HPA) axis function in HIV-1B infected individuals. However, no such investigations on the effect of HIV-1 clade C infection, particularly during the initial phase of the disease progression, have been reported. The present investigations were carried out longitudinally over a 2-year period at 12 monthly intervals in clinically asymptomatic HIV-1 clade C seropositive patients (n=120) and seronegative control subjects (n=29). We determined both the basal levels and the dynamic changes in plasma levels of norepinephrine (NE), epinephrine (E), adrenocorticotrophic hormone (ACTH) and cortisol (CORT). Studies were also extended longitudinally (at three separate yearly visits of each participant), to evaluate the response of autonomic and HPA axis to mirror star tracing challenge test (MSTCT) and the values were determined as area under the curve (AUC, corrected for baseline levels of NE, E, ACTH, and CORT). The findings show that the values of basal plasma NE levels, as well as NE response to MSTCT (AUC) at the first visit of HIV-1 seropositive individuals did not differ from those found in the control subjects (NE, pg/ml, HIV-1C=313.5±12.7 vs. controls=353.0±21.3; p=NS; AUC, HIV-1C=225±14.75 vs. controls=232.7±19.34; p=NS, respectively). At the subsequent two visits of HIV-1 positive patients however, NE response to MSTCT challenge was progressively attenuated (AUC=235±19.5 and 162.7±13.6; p<0.01 and 0.05, respectively) compared to that found at the first visit. On the other hand, plasma levels of E as well as E response to MSTCT at the first visit were significantly lower in HIV-1C seropositive individuals compared to those in the control subjects (pg/ml, HIV-1C=77.30±5.7 vs. controls=119.1+10.5; p<0.05; AUC, HIV-1C =83.29±7.5 vs. controls=172.3±18.9; p<0.001), but no further change was observed in AUC of E in response to MSTCT at the two subsequent yearly visits. The basal plasma levels of ACTH in HIV-1C seropositives were not different than in the control subjects (pg/ml: HIV-1C=20.0±0.9 vs. controls=23.1±1.6; p=NS), but ACTH response to MSTCT in HIV-1C seropositive patients at the first visit was lower than in the controls (AUC, HIV-1C=23.57±1.5 vs. controls=30.94±3.5; p<0.05), and fluctuated between high and low at the second and third visits (AUC, 28.89±2.3 and 21.69±2.36, respectively). However, the baseline plasma levels of cortisol as well as the response of cortisol to MSTCT (AUC) in HIV-1C seropositive individuals were higher than in the control subjects at the first visit (μg/dl, HIV-1C=9.83±0.39 vs. controls=6.3±0.56; p<0.05; AUC, HIV-1C=12.31±0.7 vs. control=9.18±0.9; p<0.05), and remained high at the two subsequent yearly follow up visits of HIV-1C (AUC, 11.8±0.86 and 11.98±0.77, respectively). These findings demonstrate attenuated autonomic functions, a disconnection between response of ACTH and cortisol to the MSTCT challenge, and an inverse relationship between plasma levels of catecholamine(s) and cortisol. Since plasma catecholamines and cortisol are the peripheral mediators of the autonomic and HPA axis function, the findings of this study reflect the overall adverse effect of HIV-1C infection on autonomic as well as HPA axis functions. The findings, apart from being the first to demonstrate the progressive dysregulation of autonomic nervous system and HPA axis function among HIV-1C infected seropositive individuals much ahead of the onset of acquired immunodeficiency syndrome (AIDS), also suggest that MSTCT, involving visuoconstructive cognitive abilities, is an effective stressor for unraveling the underlying dysfunctions in the neuroendocrine functions in health and disease.",
keywords = "ACTH, Autonomic nervous system, Cortisol, Epinephrine, HIV-1C, HPA-axis, Mirror star tracing challenge test, Norepinephrine",
author = "Seetharamaiah Chittiprol and Adarsh Kumar and P. Satishchandra and {Taranath Shetty}, K. and {Bhimasena Rao}, {R. S.} and Subbakrishna, {D. K.} and Mariyamma Philip and Satish, {K. S.} and {Ravi Kumar}, H. and Mahendra Kumar",
year = "2008",
month = "1",
day = "1",
doi = "10.1016/j.psyneuen.2007.09.006",
language = "English",
volume = "33",
pages = "30--40",
journal = "Psychoneuroendocrinology",
issn = "0306-4530",
publisher = "Elsevier Limited",
number = "1",

}

TY - JOUR

T1 - Progressive dysregulation of autonomic and HPA axis functions in HIV-1 clade C infection in South India

AU - Chittiprol, Seetharamaiah

AU - Kumar, Adarsh

AU - Satishchandra, P.

AU - Taranath Shetty, K.

AU - Bhimasena Rao, R. S.

AU - Subbakrishna, D. K.

AU - Philip, Mariyamma

AU - Satish, K. S.

AU - Ravi Kumar, H.

AU - Kumar, Mahendra

PY - 2008/1/1

Y1 - 2008/1/1

N2 - Human immunodeficiency virus type 1 (HIV-1) infection causes a wide spectrum of abnormalities in neurological, neuropsychological, and neuroendocrinological functions. Several studies report disturbance in autonomic nervous system (ANS) and hypothalamic pituitary-adrenal (HPA) axis function in HIV-1B infected individuals. However, no such investigations on the effect of HIV-1 clade C infection, particularly during the initial phase of the disease progression, have been reported. The present investigations were carried out longitudinally over a 2-year period at 12 monthly intervals in clinically asymptomatic HIV-1 clade C seropositive patients (n=120) and seronegative control subjects (n=29). We determined both the basal levels and the dynamic changes in plasma levels of norepinephrine (NE), epinephrine (E), adrenocorticotrophic hormone (ACTH) and cortisol (CORT). Studies were also extended longitudinally (at three separate yearly visits of each participant), to evaluate the response of autonomic and HPA axis to mirror star tracing challenge test (MSTCT) and the values were determined as area under the curve (AUC, corrected for baseline levels of NE, E, ACTH, and CORT). The findings show that the values of basal plasma NE levels, as well as NE response to MSTCT (AUC) at the first visit of HIV-1 seropositive individuals did not differ from those found in the control subjects (NE, pg/ml, HIV-1C=313.5±12.7 vs. controls=353.0±21.3; p=NS; AUC, HIV-1C=225±14.75 vs. controls=232.7±19.34; p=NS, respectively). At the subsequent two visits of HIV-1 positive patients however, NE response to MSTCT challenge was progressively attenuated (AUC=235±19.5 and 162.7±13.6; p<0.01 and 0.05, respectively) compared to that found at the first visit. On the other hand, plasma levels of E as well as E response to MSTCT at the first visit were significantly lower in HIV-1C seropositive individuals compared to those in the control subjects (pg/ml, HIV-1C=77.30±5.7 vs. controls=119.1+10.5; p<0.05; AUC, HIV-1C =83.29±7.5 vs. controls=172.3±18.9; p<0.001), but no further change was observed in AUC of E in response to MSTCT at the two subsequent yearly visits. The basal plasma levels of ACTH in HIV-1C seropositives were not different than in the control subjects (pg/ml: HIV-1C=20.0±0.9 vs. controls=23.1±1.6; p=NS), but ACTH response to MSTCT in HIV-1C seropositive patients at the first visit was lower than in the controls (AUC, HIV-1C=23.57±1.5 vs. controls=30.94±3.5; p<0.05), and fluctuated between high and low at the second and third visits (AUC, 28.89±2.3 and 21.69±2.36, respectively). However, the baseline plasma levels of cortisol as well as the response of cortisol to MSTCT (AUC) in HIV-1C seropositive individuals were higher than in the control subjects at the first visit (μg/dl, HIV-1C=9.83±0.39 vs. controls=6.3±0.56; p<0.05; AUC, HIV-1C=12.31±0.7 vs. control=9.18±0.9; p<0.05), and remained high at the two subsequent yearly follow up visits of HIV-1C (AUC, 11.8±0.86 and 11.98±0.77, respectively). These findings demonstrate attenuated autonomic functions, a disconnection between response of ACTH and cortisol to the MSTCT challenge, and an inverse relationship between plasma levels of catecholamine(s) and cortisol. Since plasma catecholamines and cortisol are the peripheral mediators of the autonomic and HPA axis function, the findings of this study reflect the overall adverse effect of HIV-1C infection on autonomic as well as HPA axis functions. The findings, apart from being the first to demonstrate the progressive dysregulation of autonomic nervous system and HPA axis function among HIV-1C infected seropositive individuals much ahead of the onset of acquired immunodeficiency syndrome (AIDS), also suggest that MSTCT, involving visuoconstructive cognitive abilities, is an effective stressor for unraveling the underlying dysfunctions in the neuroendocrine functions in health and disease.

AB - Human immunodeficiency virus type 1 (HIV-1) infection causes a wide spectrum of abnormalities in neurological, neuropsychological, and neuroendocrinological functions. Several studies report disturbance in autonomic nervous system (ANS) and hypothalamic pituitary-adrenal (HPA) axis function in HIV-1B infected individuals. However, no such investigations on the effect of HIV-1 clade C infection, particularly during the initial phase of the disease progression, have been reported. The present investigations were carried out longitudinally over a 2-year period at 12 monthly intervals in clinically asymptomatic HIV-1 clade C seropositive patients (n=120) and seronegative control subjects (n=29). We determined both the basal levels and the dynamic changes in plasma levels of norepinephrine (NE), epinephrine (E), adrenocorticotrophic hormone (ACTH) and cortisol (CORT). Studies were also extended longitudinally (at three separate yearly visits of each participant), to evaluate the response of autonomic and HPA axis to mirror star tracing challenge test (MSTCT) and the values were determined as area under the curve (AUC, corrected for baseline levels of NE, E, ACTH, and CORT). The findings show that the values of basal plasma NE levels, as well as NE response to MSTCT (AUC) at the first visit of HIV-1 seropositive individuals did not differ from those found in the control subjects (NE, pg/ml, HIV-1C=313.5±12.7 vs. controls=353.0±21.3; p=NS; AUC, HIV-1C=225±14.75 vs. controls=232.7±19.34; p=NS, respectively). At the subsequent two visits of HIV-1 positive patients however, NE response to MSTCT challenge was progressively attenuated (AUC=235±19.5 and 162.7±13.6; p<0.01 and 0.05, respectively) compared to that found at the first visit. On the other hand, plasma levels of E as well as E response to MSTCT at the first visit were significantly lower in HIV-1C seropositive individuals compared to those in the control subjects (pg/ml, HIV-1C=77.30±5.7 vs. controls=119.1+10.5; p<0.05; AUC, HIV-1C =83.29±7.5 vs. controls=172.3±18.9; p<0.001), but no further change was observed in AUC of E in response to MSTCT at the two subsequent yearly visits. The basal plasma levels of ACTH in HIV-1C seropositives were not different than in the control subjects (pg/ml: HIV-1C=20.0±0.9 vs. controls=23.1±1.6; p=NS), but ACTH response to MSTCT in HIV-1C seropositive patients at the first visit was lower than in the controls (AUC, HIV-1C=23.57±1.5 vs. controls=30.94±3.5; p<0.05), and fluctuated between high and low at the second and third visits (AUC, 28.89±2.3 and 21.69±2.36, respectively). However, the baseline plasma levels of cortisol as well as the response of cortisol to MSTCT (AUC) in HIV-1C seropositive individuals were higher than in the control subjects at the first visit (μg/dl, HIV-1C=9.83±0.39 vs. controls=6.3±0.56; p<0.05; AUC, HIV-1C=12.31±0.7 vs. control=9.18±0.9; p<0.05), and remained high at the two subsequent yearly follow up visits of HIV-1C (AUC, 11.8±0.86 and 11.98±0.77, respectively). These findings demonstrate attenuated autonomic functions, a disconnection between response of ACTH and cortisol to the MSTCT challenge, and an inverse relationship between plasma levels of catecholamine(s) and cortisol. Since plasma catecholamines and cortisol are the peripheral mediators of the autonomic and HPA axis function, the findings of this study reflect the overall adverse effect of HIV-1C infection on autonomic as well as HPA axis functions. The findings, apart from being the first to demonstrate the progressive dysregulation of autonomic nervous system and HPA axis function among HIV-1C infected seropositive individuals much ahead of the onset of acquired immunodeficiency syndrome (AIDS), also suggest that MSTCT, involving visuoconstructive cognitive abilities, is an effective stressor for unraveling the underlying dysfunctions in the neuroendocrine functions in health and disease.

KW - ACTH

KW - Autonomic nervous system

KW - Cortisol

KW - Epinephrine

KW - HIV-1C

KW - HPA-axis

KW - Mirror star tracing challenge test

KW - Norepinephrine

UR - http://www.scopus.com/inward/record.url?scp=37549027661&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=37549027661&partnerID=8YFLogxK

U2 - 10.1016/j.psyneuen.2007.09.006

DO - 10.1016/j.psyneuen.2007.09.006

M3 - Article

VL - 33

SP - 30

EP - 40

JO - Psychoneuroendocrinology

JF - Psychoneuroendocrinology

SN - 0306-4530

IS - 1

ER -